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Introduction: Primary squamous cell carcinoma of the pancreas is a rare tumor with poor prognosis and is found
in the literature only as case reports. The optimal management course remains poorly defined. We present a case
of primary basaloid squamous cell carcinoma of the pancreas metastatic to the liver, which was treated with
surgery and systemic chemotherapy. Our patient survived for 15 months: the longest survival reported in the
literature to date.
Case presentation: A 70-year-old Caucasian man presented to hospital with a three-month history of weight loss,
pruritus and icterus. Imaging studies confirmed the presence of an operable mass lesion in the head of the
pancreas. Following a pancreaticoduodenectomy, histology results led us to make a diagnosis of squamous cell
carcinoma. Postoperative restaging showed multiple metastases in the liver. He underwent palliative systemic
chemotherapy with cisplatin and 5-fluorouracil achieving partial response and an excellent quality of life. He then
went on to start second-line chemotherapy, but unfortunately died of sepsis soon thereafter.
Conclusions: This case report emphasizes that achievement of a worthwhile objective and symptomatic palliative
response is possible using platinum-based chemotherapy in squamous cell carcinoma of the pancreas.Introduction
Squamous cell carcinoma of the pancreas is rare. Squa-
mous cells are not present in the normal pancreas and
hence the pathogenesis of this carcinoma remains uncer-
tain. Even though squamous cell carcinomas arising in
other parts of the body are considered to be radiosensi-
tive and chemosensitive, and sometimes have better
outcomes, the prognosis of squamous cell carcinoma in
the pancreas remains poor, as for other pancreatic
carcinomas.Case presentation
A 70-year-old Caucasian man who was a non-smoker
presented to our facility with a three-month history of
12kg weight loss and recent generalized itching and
jaundice. Serum biochemistry and ultrasound of the ab-
domen confirmed obstructive jaundice due to a mass in* Correspondence: ravi.kodavatiganti@wales.nhs.uk
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distribution, and reproduction in any mediumthe head of the pancreas. The lesion was 4.6×4.1cm in
size with no evidence of metastatic disease on staging
computed tomography (CT) scan. He underwent endo-
scopic retrograde cholangiopancreatography (ERCP)
with a 5cm 10F plastic stent inserted into the common
bile duct followed by pylorus-sparing pancreaticoduode-
nectomy two months after diagnosis and recovered
uneventfully.
Macroscopically, there was a 5.5cm diameter, lobulated
tumor within the head of the pancreas extending to the
superior mesenteric vessel margin. This entire tumor
was sampled for histological examination. Microscopic-
ally, the tumor was composed of large nests of basaloid
cells with areas of central necrosis (Figure 1) and scat-
tered small foci of squamoid differentiation (Figure 2).
There was no evidence of acinar or glandular differenti-
ation morphologically. There was extensive intravenous
and intralymphatic invasion, together with foci of peri-
neural invasion. The tumor invaded into the duodenum,
around the base of the ampulla, into the pancreatic duct
and widely into peripancreatic fat. Tumor involvemententral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Low power image of the carcinoma with central
necrosis and focal squamous differentiation at right edge
(arrow).
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microscopically. Metastatic tumor (with similar morph-
ology) was present in six of 43 sampled lymph nodes.
The morphological appearances of the tumor were
considered to be those of a poorly differentiated (basa-
loid) squamous cell carcinoma, which was confirmed
with diffuse strong immunostaining with cytokeratin 5/6
and p63. Adenosquamous carcinoma and pancreatoblas-
toma were considered in the differential diagnosis. Ade-
nosquamous carcinoma is a rare variant of pancreatic
ductal adenocarcinoma, showing both glandular differen-
tiation and squamous differentiation. However, no glan-
dular differentiation was seen in our tumor, despite
extensive sampling. Pancreatoblastoma occurs in child-
hood, but rare cases have been described in adults. By
definition, it shows acinar differentiation and squamoid
nests. However, our tumor showed no acinar growth pat-
tern and no immunostaining with trypsin or α-fetopro-
tein. There were only occasional neuroendocrine cells
(immunopositive for synaptophysin and CD56) within
the tumor, ruling out a neuroendocrine carcinoma.Figure 2 Higher power image with desmoplastic stroma at top
and squamous pearls amongst the carcinoma cells (arrows).Squamous cell carcinoma of the pancreas is extremely
rare and, therefore, the possibility was raised that this
could be secondary involvement of the pancreas. A repeat
staging CT scan was performed postoperatively and
revealed possible metastatic spread to the liver, but did not
identify any other tumor sites. He underwent an [18F]-2-
fluoro-2-deoxy-D-glucose (FDG) positron emission
tomography-computed tomography (PET-CT) scan one
month postoperatively, which was reported to show FDG
avid lesions in both lobes of the liver and a solitary FDG
avid lymph node anterior to the renal vein. Again, no other
occult potential primary site was visible. Two months after
surgery, he started systemic palliative chemotherapy with
intravenous cisplatin at 80mg/m2 given on day one and 5-
fluorouracil 4000mg/m2 as continuous intravenous infu-
sion over four days (days one to five). On completion of
eight three-weekly cycles, restaging CTscan demonstrated
what amounted to a partial response in his liver metastases
by Response Evaluation Criteria In Solid Tumors
(RECIST) scoring. Following this he was then placed on
follow-up, achieving an excellent quality of life.
He remained active but developed epigastric pain six
months later. A restaging CT scan showed progression
in the previously noted metastatic liver disease and a
3.3cm mass in the retroperitoneum, suggestive of local
recurrence. As he remained active with performance sta-
tus of 1 on the WHO scale, he commenced second-line
chemotherapy with docetaxel a month later. Four days
after the first cycle of docetaxel had been administered
he was admitted to hospital with sepsis. Blood cultures
obtained on admission grew Klebsiella pneumoniae and
Clostridium perfringens sensitive to ciprofloxacin, tazo-
cin, gentamicin and metronidazole. Despite treatment
with tazocin and gentamicin he died of sepsis within
48 hours of admission.
Discussion
Primary squamous cell carcinoma of the pancreas is an ex-
tremely rare entity with an incidence of 0.5% to 2% of all
exocrine pancreatic neoplasms [1]. Cases are described in
the literature only as case reports [2-11]. In view of its rar-
ity, squamous cell carcinoma (SCC) in the pancreas is pre-
sumed to be metastatic from another primary site, until
proven otherwise [1,8]. However, it should be noted that
metastases to the pancreas are also rare. Metastatic spread
of primary lung SCC to the pancreas is noted to be com-
mon in both surgical and autopsy series with pancreatic
involvement usually occurring as part of widespread dis-
ease [1]. A case of an isolated metastasis from asymptom-
atic occult esophageal squamous cell cancer to the
pancreas has also been reported to masquerade as primary
pancreatic cancer [12].
Our patient was presumed to have operable primary
pancreatic cancer. The surprise histological finding of
Figure 4 Computed tomography scan showing multiple liver
metastases prior to second-line palliative chemotherapy.
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may have been a metastatic deposit and a PET-CT scan
was thus performed to attempt to localize a possible occult
primary. However, the PET-CT scan showed only multiple
liver metastases and no other candidate primary site
(Figures 3 and 4). Historically, most of the reported
cases used CTscans of head, neck and chest, otorhinolaryn-
gological examination and endoscopic examination of the
gastrointestinal tract to search for the primary. To the best
of our knowledge, this is the only reported case to have
used a PET-CTscan to search for the primary in this context.
We undertook a MEDLINE database search to identify
cases of pure squamous cell carcinoma of the pancreas
reported in the English literature and their management
and outcomes using the following key words: carcinoma,
squamous cell, pancreas, exocrine, pancreatic neoplasms.
Brown et al. in 2005 identified 36 autopsy/registry cases
of pure squamous cell carcinoma of the pancreas and 25
cases diagnosed based on ante-mortem histology results
[10]. We have identified (Table 1) an additional 14 cases
diagnosed ante-mortem since 2005 and a further case
diagnosed ante-mortem in 2000 by Fonseca et al. [11],
which was not included in the excellent review by Brown
et al. [10]. Including the present case, a total of 40 cases
of pure squamous cell carcinoma of the pancreas, diag-
nosed based on histology findings, have been reported in
the English literature.
The normal pancreas is devoid of squamous cells and
the origin of pancreatic SCC is uncertain. VariousFigure 3 Positron emission tomography-computed tomography scan
pancreaticoduodenectomy and prior to first-line palliative chemothermechanisms postulated for evolution of pure squamous
cell carcinoma include malignant transformation of
squamous metaplasia, squamous metaplastic change in a
pre-existing adenocarcinoma, and differentiation with
malignant transformation of primitive multipotent cells
[1]. Squamous metaplasia occurs in chronic pancreatitis
and following pancreatic/biliary stents. However, our pa-
tient had no previous episodes of pancreatitis and the
stent was only inserted pre-operatively.showing multiple liver metastasis immediately post-
apy.





Age Sex Race Presenting
symptom(s)
Location Size Surgery Outcome Treatment Time to death
(months)









Mansfield et al. [3] 2010 8 64 (median) 6M+2F NA Jaundice (4/8),
abdominal
discomfort (3/8),
back pain (1/8), early
satiety (1/8)
NA NA 1 (S), 1(S+R), 3 (S+R+C),
1 (C), 2 (P)
NA NA Median five
months




Distant metastasis Nil Three
months








Not known Not known
Rana et al. [6] 2009 1 50 M NA Abdominal pain,
jaundice,
weight loss
















Al-Shehri et al. [8] 2008 1 48 F NA Abdominal pain,
jaundice,
weight loss










2006 1 72 M NA Painless jaundice Head 6cm Palliative bypass surgery Nil Four months
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agement of this rare cancer as for the much more
common ductal adenocarcinoma of the pancreas. Me-
dian survival for pancreatic SCC was noted to be
seven months, with a range of six to 16 months, in
the seven patients who underwent curative resection
[10]. In our literature search we identified three
patients whose overall survival was three, 10 and
11 months following curative resection [2,4,7]. We
could not establish the overall survival of the fourth
patient who had curative resection from the Mayo
clinic series [3]. Median survival for those who did not
have curative resection was three months (range one-
quarter of a month to nine months) [3,10]. A total of
17 out of 39 patients had treatment for locally
advanced, recurrent or metastatic squamous cell cancer
of pancreas. The treatment included systemic chemo-
therapy and/or radiotherapy. Cisplatin was used in
combinations with fluorouracil (three patients) [10,13],
etoposide (one patient) [10] and vinblastine (one pa-
tient) [10]. Gemcitabine was used in combination with
carboplatin (one patient) [8] and fluorouracil (one pa-
tient) [10]. The survival in these patients was poor ex-
cept for one patient who recurred locally after surgery
at four months. He received local radiotherapy and
had an overall survival of 11 months.
Even though our patient relapsed early after surgery
with multiple liver metastases, he appears to have bene-
fited considerably from palliative systemic chemother-
apy. He achieved an overall survival of 15 months from
the surgery. He tolerated chemotherapy well and had a
good quality of life during chemotherapy and for the
majority of the seven months between completing
chemotherapy and his presentation with symptomatic
relapse. We elected to treat our patient with a platinum-
based systemic chemotherapy regimen as it is active and
used in various combinations for treatment of squamous
cell carcinomas arising at different sites including lung,
head and neck, cervix and skin.
Conclusions
Pure primary squamous cell carcinoma of the pancreas
is a rare carcinoma and, therefore, spread from other
primary squamous cell cancers should always be consid-
ered and carefully excluded. Surgery remains the corner
stone of treatment but unfortunately is not curative with
the clinical course complicated by local and/or distant
relapses. This current case report emphasizes that
achievement of a worthwhile objective and symptomatic
palliative response is possible using platinum-based
chemotherapy in squamous cell carcinoma of the pan-
creas. The treatment of these rare cancers is challenging
and may only be improved by centralized national
registries.Consent
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